Most inborn errors of immunity (IEIs) are caused by defects that arise somewhere along the developmental path between hematopoietic stem cells (HSCs) and mature immune cells. Replacement of mutant ...

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

A research team led by associate professors Yohei Funakoshi and Kimikazu Yakushijin and Professor Hironobu Minami of the ...

A prospective Polish study shows that patients who develop graft-versus-host disease in the first six months after allogeneic ...

Severe aplastic anemia is one of the most unforgiving diagnoses in hematology. The bone marrow, the factory that manufactures ...

Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with a partial match drawn from ...

Researchers demonstrated that haplo-HSCT, combined with post-transplant cyclophosphamide, is a feasible and effective treatment for hematologic malignancies even in resource-limited settings.

One of the greatest medical success stories in recent years is the successful treatment of acute leukemia in children. Just a few decades ago, mortality was universal. Now, survival has improved to ...

Efficacy and safety of busulfan-fludarabine versus busulfan-cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplant in hematologic malignancy patients: A meta-analysis ...

A recent retrospective study published in the Indian Journal of Critical Care Medicine in September 2026 highlights a ...